{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-025324","form_type":"8-K","ticker":"IBRX","cik":"0001326110","company_name":"ImmunityBio, Inc.","filed_at":"2025-02-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.306720+00:00","generated_at":"2026-05-26T22:08:27.716908+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"ImmunityBio approves executive compensation: 2024 bonuses, 2025 equity grants, salary increases","bullets":["2024 cash bonuses paid at 80% of target: Soon-Shiong $372,600, Adcock $477,600, Sachs $230,143; payable March 14, 2025.","2025 LTIP RSU grants: Soon-Shiong 822,368, Adcock 822,368, Sachs 246,710; vest ratably over 3 years.","Option grants at $3.39 strike: Soon-Shiong 2,812,500 NQSO, Adcock 2,812,500 ISO, Sachs 843,750 ISO.","2025 base salaries effective March 10: Soon-Shiong $652,050, Adcock $835,800, Sachs $592,619."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-025324","json":"https://secwatch.observer/filing/0001193125-25-025324.json","markdown":"https://secwatch.observer/filing/0001193125-25-025324.md","text":"https://secwatch.observer/filing/0001193125-25-025324.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1326110/000119312525025324/0001193125-25-025324-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1326110/000119312525025324/d933627d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T22:08:27.716908+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}